Potent Anti-Feline Immunodeficiency Virus and Anti-Human Immunodeficiency Virus Effect of IFN-τ

Journal of Immunology

Volumn 158, Issue 9, 1997, Pages 4351-4357

  Pontzer, Carol H ^a   Yamamoto, Janet K ^b   Bazer, Fuller W ^c   Ott, Troy L ^c   Johnson, Howard M ^b,d  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d PepTech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; GAMMA INTERFERON; INTERFERON; PLACENTA PROTEIN; RNA DIRECTED DNA POLYMERASE; TROPHOBLAST PROTEIN 1;

ANIMAL; ARTICLE; CAT; CELL CULTURE; DOG; DRUG EFFECT; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; SHEEP; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CATS; CELLS, CULTURED; DOGS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERON ALFA-2B; INTERFERON TYPE I; INTERFERON TYPE II; PREGNANCY PROTEINS; RNA-DIRECTED DNA POLYMERASE; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 0031132288     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. DeWit, R., J. K. M. E. Schattenkerk, C. A. B. Boucher, P. J. M. Bakker, K. H. N. Veenhof, and S. A. Danner. 1988. Clinical and virological effects of high-dose recombinant interferon-α in disseminated AIDS-related Kaposi's sarcoma. Lancet 2:1214.
2. Lane, H. C., J. A. Kovacs, J. Feinberg, B. Herpin, V. Davey, R. Walker, L. Deyton, J. A. Metcalf, M. Baseler, N. Salzman, J. Manischewitz, G. Quínnan, H. Masur, and A. S. Fauci. 1988. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma. Lancet 2:1218.
3. Lane, H. C., V. Davey, J. A. Kovacs, J. Feinberg, J. A. Metcalf, B. Herpin, R. Walker, L. Deyton, R. Davey, J. Falloon, M. A. Polis, N. P. Salzman, M. Baseler, H. Masur, and A. S. Fauci. 1990. Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection: a randomized, placebo-controlled trial. Ann. Intern. Med. 112:805.
4. Wang, C.-Y. E., A. L. Schroeter, and W. P. D. Su. 1995. Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clin. Proc. 70:869.
5. Krown, S. E., F. X. Real, S. Cunningham-Rundles, P. L. Myskowski, B. Koziner, S. Fein, A. Mittelman, H. F. Oettgen, and B. Safai. 1983. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N. Engl. J. Med. 308:1071.
6. Scadden, D. T., H. A. Bering, J. D. Levine, J. Bresnahan, L. Evans, C. Epstein, and J. E. Groopman. 1991. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alpha and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J. Clin. Oncol. 9:802.
7. Johnson, V. A., D. P. Merrill, J. A. Videler, T.-C. Chou, R. E. Byington, J. J. Eron, R. T. D'Aquila, and M. S. Hirsh. 1991. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-α inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro. J. Infect. Dis. 164:646.
8. Krown, S. E., J. W. M. Gold, D. Niedzwiecki, D. Bundow, N. Flomenberg, B. Gansbacher, and B. J. Brew. 1990. Interferon-α with zidovudine: safety, tolerance, and clinical and virologie effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 12:812.
9. Richman, D. D. 1996. HIV therapeutics. Sci. 272:1886.
10. Abramowicz, M., ed. 1996. New drugs for HIV infection. Med. Lett. Drugs Ther. 38:35.
11. Koup, R. A., F. Brewster, P. Grob, and J. L. Sullivan. 1993. Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin. AIDS 7:1181.
12. Pagano, P. J., and K.-T. Chong. 1995. In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-α. J. Infec. Dis. 171:61.
13. 2-interferon. Proc. Natl. Acad. Sci. USA 86:4958.
14. Weir, J. P., and K. L. Elkins. 1993. Replication-incompetent herpesvirus vector delivery of an interferon α gene inhibits human immunodeficiency virus replication in human monocytes. Proc. Natl. Acad. Sci. USA 90:9140.
15. Su, Y., W. Popik, and P. M. Pitha. 1995. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells. J. Virol. 69: 110.
16. Francis, M. L., M. S. Meltzer, and H. E. Gendelman. 1992. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res. Hum. Retrovirol. 8:199.
17. Pitha, P. M. 1991. Multiple effects of interferon on HIV-1 replication. J. Interferon Res. 11:313.
18. Baca-Regen, L., N. Heinzinger, M. Stevenson, and H. E. Gendelman. 1994. Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J. Virol. 68:7559.
19. Kornbluth, R. S., P. S. Oh, J. R. Munis, P. H. Cleveland, and D. D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169: 1137.
20. Gendelman, H. E., L. M. Baca, J. Turpin, D. C. Kalter, B. Hansen, J. M. Orenstein, C. W. Dieffenbach, R. M. Friedman, and M. S. Meltzer. 1990. Regulation of HIV replication in infected monocytes by IFN-α: mechanisms for viral restriction. J. Immunol. 145:2669.
21. Godkin, J. D., F. W. Bazer, J. Moffatt, F. Sessions, and R. M. Roberts. 1982. Purification and properties of a major, low molecular weight protein released by the trophoblast of sheep blastocysts at day 13-21. J. Reprod. Fertil. 65:141.
22. Imakawa, K., R. Y. Anthony, M. Kazemi, K. R. Marotti, H. G. Polites, and R. M. Roberts. 1987. Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature 330:377.
23. Duc-Goiran, P., B. Robert-Galliot, J. Lopez, and C. Chany. 1985. Unusual apparently constitutive interferons and antagonists in human placental blood. Proc. Natl. Acad. Sci. USA 82:5010.
24. Chard, T., P. H. Craig, M. Menabaway, and C. Lee. 1986. Alpha interferon in human pregnancy. Br. J. Obstet. Gynaecol. 93:1145.
25. Whaley, A. E., C. S. R. Meka, L. A. Harbison, J. S. Hunt, and K. Imakawa, 1994. Identification and cellular localization of unique interferon mRNA from human placenta. J. Biol. Chem. 269:10864.
26. Roberts, R. M., J. C. Cross, and D. W. Leaman. 1992. Interferons as hormones of pregnancy. Endocr. Rev. 13:432.
27. Stewart, H. J., S. H. E. McCann, P. J. Barker, K. E. Lee, G. E. Lamming, and A. P. F. Flint. 1987. Interferon sequence homology and receptor binding activity of ovine trophoblast antiluteolytic protein. J. Endocrinol. 115:R13.
28. Pontzer, C. H., F. W. Bazer, and H. M. Johnson. 1991. Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res. 551:5304.
29. Pontzer, C. H., B. A. Torres, J. L. Vallet, F. W. Bazer, and H. M. Johnson. 1988. Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem. Biophys. Res. Commun. 152:801.
30. Chang, C. D., and J. Meienhofer. 1978. Solid-phase peptide synthesis using mild base cleavage of Nα-fluoroenylmethyloxycarbonyl amino acids, exemplified by a synthesis of dihydrosomalostatin. Int. J. Peptide Protein Res. 11:246.
31. Familletti, P. C., S. Rubinstein, and S. Pestka. 1981. A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol. 78:387.
32. Yamamoto, J. K., C. D. Ackley, H. Zochlinski, H. Louie, E. Pembroke, M Torten, H. Hansen, R. Munn, and T. Okuda. 1991. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines. Intervirology 32:361.
33. Yamatoto, J. K., F. Barré-Sinoussi, V. Bolton, N. C. Pedersen, and M. B. Gardner. 1986. Human alpha- and beta-interferon but not gamma suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J. Interferon Res. 6:143.
34. Rey, M. H., B. Spire, D. Dormont, F. Barré-Sinoussi, L. Montagnier, and J. C. Cher-Mann. 1984. Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem. Biophys. Res. Commun. 121:126.
35. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790.
36. Pontzer, C. H., T. L. Ott, F. W. Bazer, and H. M. Johnson. 1990. Localization of an antiviral site on the pregnancy recognition hormone, ovine trophoblast protein1. Proc. Natl. Acad. Sci. USA 87:5945.
37. Dorr, R. T. 1993. Interferon-α in malignant and viral diseases. Drugs 45:177.
38. Oldham, R. K. 1985. Biologicals for cancer treatment: interferons. Hosp. Pract. 15:71.
39. Quesada, J. R., M. Talpaz, A. Rios, and J. U. Gutterman. 1986. Clinical toxicity of interferon in cancer patients. J. Clin. Oncol. 4:234.
40. Dianzani, F. 1992. Interferon treatments: how to use an endogenous system as a therapeutic agent. J. Interferon Res. May:109.
41. Yamamoto, J. K., T. Hohdatsu, R. A. Olmsted, R. Pu, H. Louie, H. A. Zochlinski, V. Acevedo, H. M. Johnson, G. A. Soulds, and M. B. Gardner. 1993. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67:601.
42. Bilello, J. A., N. A. Wivel, and P. M. Pitha. 1982. Effect of interferon on the replication of MCF virus in murine cells: Synthesis, processing, assembly, and release of viral proteins. J. Virol. 43:213.
43. Poli, G., J. M. Orenstein, A. Kinter, T. M. Folks, and A. S. Fauci. 1989. Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science 244:575.
44. Kornbluth, R. S., P. S. Oh, J. R. Munis, P. H. Cleveland, and D. D. Richman. 1990. The role of interferons in the control of HIV replication in macrophages. Clin. Immunol. Immunopathol. 54:200.
45. Shirazi, Y., and P. M. Pitha. 1992. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J. Virol. 66:1321.
46. I1. J. Reprod. Fertil. 93:599.
47. Soos, J. M., P. S. Subramaniam, A. C. Hobeika, J. Schiffenbauer, and H. M. Johnson. 1995. The IFN pregnancy recognition hormone IFN-τ blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J. Immunol. 155:2747.
48. Subramaniam, P. S., S. A. Khan, C. H. Pontzer, and H. M. Johnson. 1995. Differential recognition of the type I IFN receptor by IFNτ and IFNα is responsible for their differential cytotoxicities. Proc. Natl. Acad. Sci. USA 92:12270.
49. Li, J., and R. M. Roberts. 1994. Structure-function relationships in the interferon-τ (IFN-τ): changes in receptor binding and in antiviral and antiproliferative activities resulting from site-directed mutagenesis performed near the carboxyl terminus. J. Biol. Chem. 269:24826.
50. Jarpe, M. A., H. M. Johnson, F. W. Bazer, T. L. Ott, E. V. Curto, N. Rama Krishna, and C. H. Pontzer. 1994. Predicted structural motif of IFNτ. Protein Eng. 7:863.
51. Ott, T. L., G. Van Heeke, H. M. Johnson, and F. W. Bazer. 1991. Cloning and expression in Saccharomyces cerevisiae of a synthetic gene for the type-1 trophoblast interferon ovine trophoblast protein-1: purification and antiviral activity. J. Interferon Res. 11:357.